Cargando…

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial

BACKGROUND: Cisplatin is a key drug in lung cancer therapy. However, cisplatin is also well known to induce gastrointestinal disorders, such as chemotherapy-induced nausea and vomiting, anorexia, and weight loss. These symptoms sometimes affect patients’ quality of life and make continuation of chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Takuya, Takagi, Hironori, Owada, Yuki, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Yokouchi, Hiroshi, Kanazawa, Kenya, Ohbuchi, Katsuya, Fukushima, Takahisa, Munakata, Mitsuru, Suzuki, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648481/ https://www.ncbi.nlm.nih.gov/pubmed/29047408 http://dx.doi.org/10.1186/s13063-017-2227-6

Ejemplares similares

Clinical significance of expanded Foxp3(+) Helios(−) regulatory T cells in patients with non-small cell lung cancer
por: MUTO, SATOSHI, et al.
Publicado: (2015)

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma
por: Osugi, Jun, et al.
Publicado: (2015)

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
por: Hasegawa, Takeo, et al.
Publicado: (2019)

FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer
por: Higuchi, Mitsunori, et al.
Publicado: (2016)

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report
por: Osugi, Jun, et al.
Publicado: (2016)

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden
por: Muto, Satoshi, et al.
Publicado: (2021)

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
por: Muto, Satoshi, et al.
Publicado: (2023)

Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract
por: Tominaga, Kazunari, et al.
Publicado: (2015)

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor
por: Yamaura, Takumi, et al.
Publicado: (2018)

Beneficial Effects of Rikkunshito, a Japanese Kampo Medicine, on Gastrointestinal Dysfunction and Anorexia in Combination with Western Drug: A Systematic Review
por: Mogami, Sachiko, et al.
Publicado: (2014)

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
por: Suzuki, Hiroyuki, et al.
Publicado: (2013)

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib
por: Matsumura, Yuki, et al.
Publicado: (2021)

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips
por: Matsumura, Yuki, et al.
Publicado: (2022)

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report
por: Watanabe, Masayuki, et al.
Publicado: (2022)

Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model
por: Terawaki, Kiyoshi, et al.
Publicado: (2017)

Rikkunshito and Ghrelin
por: Hattori, Tomohisa
Publicado: (2010)

Rikkunshito Ameliorates Cancer Cachexia Partly through Elevation of Glucarate in Plasma
por: Ohbuchi, Katsuya, et al.
Publicado: (2015)

Rikkunshito, a Japanese Kampo Medicine, Ameliorates Decreased Feeding Behavior via Ghrelin and Serotonin 2B Receptor Signaling in a Novelty Stress Murine Model
por: Yamada, Chihiro, et al.
Publicado: (2013)

Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014)

Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs
por: Takagi, Hironori, et al.
Publicado: (2022)

A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction
por: Saegusa, Yayoi, et al.
Publicado: (2015)

Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans
por: Ohno, Tetsuro, et al.
Publicado: (2011)

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials
por: Harada, Toshiyuki, et al.
Publicado: (2018)

Ghrelin Enhancer, the Latest Evidence of Rikkunshito
por: Yamada, Chihiro, et al.
Publicado: (2021)

The effect of standard and high dose of rikkunshito on achievement of enteral nutrition target in critically ill patients: a pilot randomized controlled trial
por: Doi, Mitsunori, et al.
Publicado: (2019)

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung
por: Takagi, Hironori, et al.
Publicado: (2023)

Use of Kampo Diagnosis in Randomized Controlled Trials of Kampo Products in Japan: A Systematic Review
por: Motoo, Yoshiharu, et al.
Publicado: (2014)

Kampo for the Treatment of Pain in Japan: A Review
por: Arai, Young-Chang, et al.
Publicado: (2020)

Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report
por: Muto, Satoshi, et al.
Publicado: (2020)

Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Muto, Satoshi, et al.
Publicado: (2021)

The role of traditional Japanese medicine (Kampo) in the practice of psychosomatic medicine: the usefulness of Kampo in the treatment of the stress-related symptoms of women, especially those with peri-menopausal disorder
por: Ushiroyama, Takahisa
Publicado: (2013)

Prescription of Kampo Drugs in the Japanese Health Care Insurance Program
por: Katayama, Kotoe, et al.
Publicado: (2013)

Traditional herbal medicine, Rikkunshito, for chemotherapy-induced nausea and vomiting
por: Morishige, Ken-ichirou
Publicado: (2017)

Our experience of lung resection in patients who decline blood transfusion for religious reasons
por: Takagi, Hironori, et al.
Publicado: (2021)

A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer
por: Minemura, Hiroyuki, et al.
Publicado: (2015)

CRF receptor 1 antagonism and brain distribution of active components contribute to the ameliorative effect of rikkunshito on stress-induced anorexia
por: Mogami, Sachiko, et al.
Publicado: (2016)

Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux
por: Morita, Terumi, et al.
Publicado: (2012)

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019)

Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report
por: Okabe, Naoyuki, et al.
Publicado: (2021)

Statistical Analysis of Hie (Cold Sensation) and Hiesho (Cold Disorder) in Kampo Clinic
por: Yoshino, Tetsuhiro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_54jf7f61tkgeff5o47u0lmj5np